Its inhibitor fasnall is a selective FASN inhibitor that targets multiple domains of FASN, which can restrain c-Met receptor kinase and promote apoptosis of DLBCL cells [45]. The gene discussed is FASN; the disease is diffuse large B-cell lymphoma.